GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » 3-Year FCF Growth Rate
中文

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) 3-Year FCF Growth Rate : 0.90% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Carl Zeiss Meditec AG 3-Year FCF Growth Rate?

Carl Zeiss Meditec AG's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.01.

During the past 12 months, Carl Zeiss Meditec AG's average Free Cash Flow per Share Growth Rate was -86.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 0.90% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -3.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Carl Zeiss Meditec AG was 51.30% per year. The lowest was -28.50% per year. And the median was 1.10% per year.


Competitive Comparison of Carl Zeiss Meditec AG's 3-Year FCF Growth Rate

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's 3-Year FCF Growth Rate falls into.



Carl Zeiss Meditec AG 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Carl Zeiss Meditec AG  (OTCPK:CZMWF) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Carl Zeiss Meditec AG 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.